Key Takeaways
- Volume growth reset to mid-single digits: Management cut its H2 domestic volume outlook to mid-single digits, citing persistent geopolitical and inflationary pressures that have not resolved as earlier assumed.
- Deflation masked underlying performance: Price drops in Saffola (~18% from peak) and Parachute (~8%) compressed reported revenue growth; adjusting for this, India and Bangladesh volume growth would be broadly in the same zone.
- One-time Saffola margin hit taken deliberately: A 75–100 bps consolidated EBITDA margin impact was absorbed in Q2 to cut prices ahead of the market, consuming high-cost inventory and covering trade stock, a move that stabilized volumes in Q2 and October.
- Premium and digital portfolios are scaling: Premium personal care crossed pre-COVID levels, foods is on track for ₹650 Cr in FY23, and digital brands are in line with acquisition assumptions, with premium personal care carrying structurally higher gross margins than the core.
- What to watch next quarter: Whether copra and consumer prices harmonize by December as guided, the pace of rural recovery as the base softens, and any further edible oil price volatility that could force another round of Saffola price action.
Deflation & the Volume-Value Disconnect
- Parachute pricing lag: Copra corrected beyond forecasts even in off-season months, reflecting weak sentiment rather than a pure supply glut. Marico cut prices promptly, but the brand’s 40–45 day average STR means each drop takes 6–8 weeks to reach shop shelves, especially in rural areas, so price stability is expected only by December.
- Saffola’s faster pass-through: Saffola operates on 8–10 days STR with heavy modern trade and e-com contribution, allowing near-immediate price-drop benefits to trade. This structural difference let Marico reset Saffola pricing in one go during Q2, taking the margin hit upfront.
- Volume loss from grammage strategy: India lost ~1% volume growth by choosing not to take price increases and instead reducing MLH (more-gram-for-same-price), a deliberate trade-off that preserved consumer value but depressed reported volumes.
- Three-year CAGRs tell a healthier story: Even with mid-single-digit H2 volume growth, the three-year CAGR stays in high single digits, consistent with medium-term aspirations. Management urged investors to look through the current deflationary distortion.
Saugata Gupta: "Saffola in fact is around 18% drop from the peak and Parachute we have taken around 8% price drop which is not the case in Bangladesh so I think that would be the reason so therefore if I had an inflation I would have also delivered with a 3% volume growth..."
Category Health & Consumer Stress
- Bottom-of-pyramid downtrading: In high-penetration HPC categories like hair oils, soaps, and shampoos, consumers do not titrate usage, they downgrade across price points. VAHO, with its rural skew, is directly exposed to this dynamic and posted subdued growth; mid and premium segments within hair oils fared relatively better.
- Rural stress is recent and sharp: Over a five-year period, rural has outperformed urban; only this year has urban grown faster. The rural slowdown began in Q3 last year, so H2 FY23 enters a softer base that management expects will aid recovery, alongside government spending in election mode.
- Premium discretionary insulated: Premium personal care, modern trade, and e-com-driven brands are not seeing the same stress; the segment has crossed pre-COVID levels after being depressed through FY20–22. LUPs are growing, consistent with consumers protecting food spend and compressing FMCG.
- Loose-to-branded conversion stalled: Parachute’s 3% volume decline (category declined slightly more) reflects two pressures: loose-to-branded conversion has slowed, and in dual-usage households, the share of requirement sourced from branded packs may have dropped.
Saugata Gupta: "In some core categories like soap, hair oils and shampoos you do not see titration in usage but you see a down-gradation and any high penetration category there is this opportunity for down-gradation because there are different price points different brands play."
Saffola Edible Oil: The Deliberate Reset
- Q1 shock drove Q2 strategy: After a Q1 dip, Marico cut Saffola prices substantially in one go, ahead of the market, while still consuming higher-cost RM inventory and covering all ground stock in the trade to effect the cut. The total one-time impact was 75–100 bps on consolidated EBITDA margins, but it stabilized volumes in Q2 and October.
- Volume recovery achieved: Saffola delivered high single-digit volume growth in Q2; destocking has occurred and STR has not increased. The edible oil control limit was lifted only two days before the call, so volatility remains a live risk.
- No further price cuts post-September: Management signaled a wait-and-watch stance on future Saffola pricing, declining to commit given end-of-October edible oil volatility. The strategy now is to balance volume growth and profitability at sustainable levels once price stability sets in.
- HORECA deliberately avoided: Management ruled out entering the HORECA channel in the near term, calling it unprofitable for a player of Marico’s size and a dilution of Saffola’s gross margin improvement objective.
Saugata Gupta: "Foods for us is something which has to deliver higher margins in Saffola edible oil because we are diversifying and expanding the total addressable market for Saffola so in this context and given our size I think this is a channel of HORECA which is not profitable."
Portfolio Diversification: Foods, Digital & Premium
| Segment | Status | Commentary |
|---|---|---|
| Foods | ▲ On track | Broad-based growth; ₹650 Cr FY23 run rate, ₹850–1,000 Cr FY24 target maintained. Soya nuggets scaling toward ₹100 Cr; noodles and peanut butter growing sequentially; mayonnaise needs work. Exclusive food GTM established in top six cities, expanding. |
| Digital brands | ▲ In line | Beardo in a virtuous growth cycle; Just Herbs and True Elements scaling; Fittify entering gummies. ₹400–500 Cr FY24 target; ₹250 Cr run rate by Q2, ₹300 Cr by year-end keeps it on track. Inorganic opportunities still being pursued. |
| Premium personal care | ▲ Above pre-COVID | Gross margin significantly higher than rest of portfolio; A&P broadly in line, so the segment improves both gross margin and EBITDA profile as it scales. |
| Honey | ▬ Transitioning | Old product phased out in September, new dual-portfolio (Active at accessible price, Gold at premium with NMR testing) launched mid-October. Slight GT share dip in Q1; MT and e-com share maintained. Management expects aggressive share gains ahead. |
| Plant protein | ▲ Early stage | Soya Bhurji launched, pilot started a week before the call. Playbook mirrors Masala Oats: drive trials, build loyalty, then move to larger packs. |
- Gross margin trajectory improving: As foods and digital brands scale, their structurally higher gross margins are expected to lift the consolidated profile sequentially. International business input costs should also ease, adding modestly to gross margins.
International: The Steady Counterweight
- Seventh consecutive quarter of double-digit constant-currency growth, with all markets contributing despite growing macro uncertainty. Bangladesh remained resilient with healthy core growth and sustained ramp-up in hair care and baby care. Vietnam gained momentum on buoyant HPC category growth; MENA posted stable growth for 18 months; South Africa and New Country Development kept tempo.
- Bangladesh diversification paying off: The playbook is being replicated in Vietnam and MENA with definitive results. Management is confident of maintaining growth momentum even if Bangladesh moderates somewhat given external headwinds.
- Currency and margin tailwind: A significant part of currency depreciation is over, though YoY impact will continue. Input cost easing should let international add modestly to gross margins sequentially.
Competitive Stance & Margin Philosophy
- Will not chase volume at any cost: Management explicitly stated it will not grow volume or market share at gross margins that are unsustainable over the medium term, and will not sacrifice medium- and long-term positioning for short-term gains. Some competitors are cutting A&P, downtrading, and compressing margins to participate in the downgrade cycle; Marico is holding the line.
- Trade partner ROI protected: The company continues to support channel partners by maintaining their ROI even when growth is muted, and has not curtailed A&P spends. This is a deliberate investment in distribution health for when demand returns.
- EBITDA margin aspiration maintained: Management reiterated the aspiration to deliver 18–19% EBITDA margin in FY23, with gross margins expected to improve sequentially from Q3 as copra stays soft and the Saffola one-time hit washes through.
Saugata Gupta: "We will not grow volume or market share at a gross margin which is somewhat unsustainable over the medium term so as an organization we will not sacrifice the medium and long term for some short term."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Domestic volume growth | Mid-single-digit volume growth in H2 | H2 FY23 |
| Parachute price stability | Copra and consumer prices to harmonize; pricing actions take 6–8 weeks to translate | By December |
| Saffola volume-profit balance | Balance volume growth and profitability at sustainable levels once price stability sets in | After price stability achieved |
| Foods revenue | ₹650 Cr in FY23; ₹850–1,000 Cr in FY24 | FY23 / FY24 |
| Digital brands revenue | ₹450–500 Cr by FY24; ₹250 Cr run rate by Q2 | FY24 |
| EBITDA margin | Aspiration to deliver 18–19% in FY23 | FY23 |
| Honey market share | Aggressively gain share with dual-portfolio strategy | From Q3 onward |
| International growth | Maintain growth momentum across markets | Coming quarters |
| ESG | Net zero emissions in domestic operations by 2030, global operations by 2040 | 2030 / 2040 |
Key Metrics
| Metric | Q2 FY23 |
|---|---|
| Consolidated revenue | ₹2,496 cr, +1% YoY |
| India business volume growth | -3% (Parachute), +8% (Saffola oils), flat (VAHO) |
| Consolidated EBITDA margin | 19.0% in H1 FY23, aspiration to deliver 18–19% in FY23 |
| One-time EBITDA margin impact (Saffola pricing) | 75–100 bps hit in Q2 |
| Gross margin outlook | Sequential improvement from Q3 |
| International business constant currency growth | Double-digit, seventh consecutive quarter |
| Foods franchise revenue run rate | ₹650 cr in FY23, aspiration of ₹850–1,000 cr in FY24 |
| Digital brands portfolio ARR | ~₹250 cr, target of ₹450–500 cr by FY24 |
| Combined run rate (Foods, Premium personal care, digital) | ~₹1,200 cr |
| Premium personal care turnover | ₹300 cr, crossed pre-COVID levels |
| Parachute 3-year volume CAGR | 4% |
| Saffola oils 3-year volume CAGR | 8% |
| Value Added Hair Oils 3-year value CAGR | 6% |
| Market share consolidated | >90% of portfolio on MAT basis |
| Saffola edible oil price drop from peak | ~18% |
| Parachute price drop taken | ~8% |
| India volume growth lost (MLH drop instead of price increase) | ~1% |
| Soya chunks expected revenue | ₹100 cr in FY23 |
| H2 domestic volume growth expectation | Mid single digit |